We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

21 hedge funds and large institutions have $4.21M invested in Zomedica Corp. in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% less capital invested

Capital invested by funds: $4.8M → $4.21M (-$584K)

16% less funds holding

Funds holding: 25 → 21 (-4)

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
21
Holders Change
-4
Holders Change %
-16%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$8.92K
2
IP
Isthmus Partners
Wisconsin
+$7.47K
3
AG
Advisor Group
Arizona
+$336
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$132

Top Sellers

Rank Fund Capital Flow
1
LP
LMR Partners
United Kingdom
-$18K
2
Renaissance Technologies
Renaissance Technologies
New York
-$13K
3
UBS Group
UBS Group
Switzerland
-$12.3K
4
Millennium Management
Millennium Management
New York
-$11K
5
Jane Street
Jane Street
New York
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
1
Cambridge Investment Research Advisors
Iowa
$4M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$98K – – –
Citadel Advisors
3
Citadel Advisors
Florida
$22K +$8.92K +26,509 +68%
IP
4
Isthmus Partners
Wisconsin
$21K +$7.47K +22,200 +53%
SG Americas Securities
5
SG Americas Securities
New York
$20K – – –
JA
6
JVL Associates
Michigan
$19K – – –
UBS Group
7
UBS Group
Switzerland
$9K -$12.3K -36,675 -58%
Wells Fargo
8
Wells Fargo
California
$9K -$824 -2,450 -8%
RIS
9
Retirement Income Solutions
Michigan
$9K – – –
Creative Planning
10
Creative Planning
Kansas
$3K – – –
VFA
11
Voya Financial Advisors
Connecticut
$3K – – –
Citigroup
12
Citigroup
New York
$2K – – –
JP Morgan Chase
13
JP Morgan Chase
New York
$1K -$783 -2,329 -42%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$1K +$132 +393 +14%
BNP Paribas Financial Markets
15
BNP Paribas Financial Markets
France
$74 -$1.76K -5,229 -96%
LP
16
LMR Partners
United Kingdom
– -$18K -47,495 Closed
Renaissance Technologies
17
Renaissance Technologies
New York
– -$13K -36,220 Closed
Millennium Management
18
Millennium Management
New York
– -$11K -30,725 Closed
Jane Street
19
Jane Street
New York
– -$7K -19,393 Closed
PP
20
Paloma Partners
Connecticut
– -$7K -18,596 Closed
Deutsche Bank
21
Deutsche Bank
Germany
– -$4.46K -13,254 -83%
Victory Capital Management
22
Victory Capital Management
Texas
– -$3K -8,817 Closed
Toronto Dominion Bank
23
Toronto Dominion Bank
Ontario, Canada
– -$79 -235 -92%
Morgan Stanley
24
Morgan Stanley
New York
– -$45 -135 -49%
AG
25
Advisor Group
Arizona
– +$336 +1,000 New

ZOM Hedge Fund Activity: Q4 2019 in Review

21 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2019, worth a combined $4.21M — down 12% from $4.8M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ZOM and 2 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 3 added.

The largest buyer was Citadel Advisors, adding an estimated $8.92K. The largest seller was LMR Partners, exiting entirely with an estimated $18K sold.

  • 21 institutional investors held Zomedica Corp. (ZOM) as of Q4 2019, down from 25 in Q3 2019.
  • Funds reported $4.21M of Zomedica Corp. stock for Q4 2019, down 12% quarter-over-quarter.
  • 2 funds opened new Zomedica Corp. positions in Q4 2019 and 6 closed out, a net change of -4 holders.
  • The largest Zomedica Corp. buyer in Q4 2019 was Citadel Advisors, an estimated $8.92K added.
  • The largest Zomedica Corp. seller in Q4 2019 was LMR Partners, an estimated $18K sold.

Based on aggregated 13F filings for Q4 2019.